HeartSciences Inc. (HSCSW)
NasdaqCM: HSCSW
· Real-Time Price · USD
0.04
+0.00 (0.00%)
At close: Aug 06, 2026, 7:55 PM
HeartSciences Inc. (HSCSW) Stock Price, Analysis & Data
0.00% (1D)
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | 4.32K |
| Net Income (ttm) | -9.14M |
| Beta | 1.80 |
| EPS (ttm) | -1.09 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 0.57 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 12 |
| Avg. Volume (20D) | |
| Open | 0.07 |
| Previous Close | 0.04 |
| Day's Range | 0.04 - 0.04 |
| 52-Week Range | 0.04 - 0.04 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About HSCSW
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional EC...
IPO Date Jul 17, 2026
Employees 14
Stock Exchange NasdaqCM
Ticker Symbol HSCSW
Website https://heartsciences.com
Financial Performance
In 2026, HeartSciences's revenue was 4.32K, a decrease of -0.71% compared to the previous year's 4.35K. Earnings were -9.14M, an increase of 4.3%.
Financial Statements
